Paramyxovirus strategies for evading the interferon response.
about
Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infectionInduction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathwayInhibition of interferon signaling by dengue virusViral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-AntagonistsPathogenesis of acute respiratory illness caused by human parainfluenza virusesAn anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon inductionInhibition of human parainfluenza virus type 3 infection by novel small moleculesRIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection.Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein.Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels.Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vectorMorbillivirus v proteins exhibit multiple mechanisms to block type 1 and type 2 interferon signalling pathwaysDifferentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins.Expression of the Sendai (murine parainfluenza) virus C protein alleviates restriction of measles virus growth in mouse cells.Measles virus V protein inhibits NLRP3 inflammasome-mediated interleukin-1β secretion.Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence.Developments towards effective treatments for Nipah and Hendra virus infection.The ubiquitin-proteasome pathway in viral infections.Collectins and cationic antimicrobial peptides of the respiratory epithelia.Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA.Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy.Nipah virus edits its P gene at high frequency to express the V and W proteins.Model-based analysis of interferon-beta induced signaling pathway.Paramyxovirus disruption of interferon signal transduction: STATus reportDifferential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene.Inhibition of the type I interferon antiviral response during arenavirus infection.The interaction between human enteroviruses and type I IFN signaling pathway.Paramyxovirus evasion of innate immunity: Diverse strategies for common targets.Proteomic alteration of PK-15 cells after infection by porcine circovirus type 2.Different functions of the common P/V/W and V-specific domains of rinderpest virus V protein in blocking IFN signallingThe STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signalingNonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist.Identification of a mutation in editing of defective Newcastle disease virus recombinants that modulates P-gene mRNA editing and restores virus replication and pathogenicity in chicken embryos.Newcastle disease virus V protein is a determinant of host range restriction.
P2860
Q24562957-E8EB3085-938F-499F-9907-E47D719963FCQ24563231-BA83A3F8-7BDF-4BFD-8DC5-960FA59B16AEQ24630622-92D97BCC-6365-46CC-8077-B62DC7CA03B8Q26745547-B89461BA-F5E1-4C21-877A-F31299AF14E7Q27000151-D122B38C-7C4F-4ADB-99DE-40E7596DBD0CQ28586940-1A6E4328-4713-4501-88A7-8AE172E3FE06Q33304137-B5350257-F4F6-43CA-956A-0709A1E3DB95Q33796488-9E718F2B-1314-4744-B8E3-A6E5A95D047FQ33843169-EF15C6EE-C46E-455B-BDCA-E8A0106DE058Q34031372-EEC8E625-3011-4BC4-865A-E9D000C417F1Q34302198-66B174CA-F4CE-473F-BF90-BE7C3262C3F2Q34595223-405361B2-6964-43BA-A78A-30DF6A6E9DB1Q34648125-8A9D760D-31A6-4374-9690-30EA4828A56AQ35023714-63EB11BB-A46B-40FC-A323-AA55002735DEQ35216882-4166B5F1-A025-42E1-A0B9-18D008B16D73Q35599347-3893929E-09F4-41F7-AB0D-A5C11EB9366EQ36096753-A5CD4DAF-C40B-421F-94E0-699C9A6819FDQ36276572-FE3D5488-2B66-42C8-B134-FEBE07CBFFBFQ36379335-03DB643F-E86A-49D7-9A95-111881A96501Q36538328-833C954F-24C9-48E5-A2CF-0F7805162D36Q36590997-6FD9397D-7FDC-461B-BE14-6073DE164A0CQ36623471-257478F7-BE40-4475-AD3B-831746E2E61AQ36845674-C3F46BA9-6C68-4D4F-86E6-F8990CAFFBDFQ36933945-F3A4272D-A555-487A-BA63-ACBFDFA58F18Q36961947-11E81ADA-D699-4F9A-96EB-68963B91F4A6Q36987415-3EBC925F-5511-4C71-AD24-73E2957A5121Q37145211-1C14985A-F1FD-4E6F-956A-A0656209CEE7Q37288924-0CF5AC0E-12BE-49C2-B8DF-22F2E0F2E252Q37582936-C113A7DD-BA41-4E6E-B34D-18395F7BEB81Q37583896-CF1D3E71-87F4-43F6-B00A-A1FD5BF50863Q37945195-63BA4095-664F-4101-90D1-506BF9E8849CQ38126917-36C483D0-F8D0-46BC-8437-95CEFBCB89F9Q38156883-68E190EA-5387-4EEB-875F-7154DC47DBF3Q38967958-2548A388-C820-470D-834E-6D68B9568EB1Q39070794-D4117164-9B94-4A34-A604-A2D76171152AQ39732576-31C62615-41F4-4DE8-9E66-5C0743DA194DQ39796610-149AFAE6-F1AB-4182-A75E-30B37EFF1F7CQ39796662-95720544-B25F-4BFE-9C46-5A75D0C32834Q39864166-1E174521-41C6-4931-8EFC-EF7AB7F9EBFCQ39864222-63834006-E22C-43AD-8975-59F211F5B8F7
P2860
Paramyxovirus strategies for evading the interferon response.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Paramyxovirus strategies for evading the interferon response.
@ast
Paramyxovirus strategies for evading the interferon response.
@en
Paramyxovirus strategies for evading the interferon response.
@nl
type
label
Paramyxovirus strategies for evading the interferon response.
@ast
Paramyxovirus strategies for evading the interferon response.
@en
Paramyxovirus strategies for evading the interferon response.
@nl
prefLabel
Paramyxovirus strategies for evading the interferon response.
@ast
Paramyxovirus strategies for evading the interferon response.
@en
Paramyxovirus strategies for evading the interferon response.
@nl
P2093
P2860
P356
P1476
Paramyxovirus strategies for evading the interferon response.
@en
P2093
Junko Yokoo
Kenji Takeuchi
Takayuki Komatsu
P2860
P304
P356
10.1002/RMV.357
P577
2002-11-01T00:00:00Z